The Unitarian Hypothesis for the aetiology of diabetes mellitus

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1115-1120

  Morrison, E Y ^a   Ragoobirsingh, D ^a   Peter, S A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANACARDIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BIXA ORELLANO EXTRACT; CALCIUM CHANNEL BLOCKING AGENT; CAPSICUM FRUTESCENS EXTRACT; CAPTOPRIL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; LOSARTAN; METFORMIN; ORAL ANTIDIABETIC AGENT; PLANT EXTRACT; RAMIPRIL; UNCLASSIFIED DRUG;

ARTICLE; CALORIC INTAKE; CLINICAL FEATURE; DETOXIFICATION; GENETIC PREDISPOSITION; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MALNUTRITION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; JAMAICA; LIFE STYLE; MODELS, BIOLOGICAL; NUTRITIONAL STATUS;

CANIS FAMILIARIS; MANIHOT ESCULENTA;

EID: 33748042310     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.061     Document Type: Article

References (31)

1. Jones H. Diabetes in Jamaica. Lancet (1955) 891-897
2. Zuidema P.J. Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition. J Trop Geog Med 11 (1959) 70-74
3. Morrison E.Y.St.A., and Richards R. Clinical profile of diabetes mellitus in Jamaica (Phasic Insulin Dependence). W Indian Med J 34 (1985) 96-97
4. Morrison E.Y.St.A., and Ragoobirsingh D.R. J-type diabetes revisited. J Nat Med Assoc 84 (1992) 603-608
5. Morrison E.Y.St.A., Ragoobirsingh D., Thompson H., Fletcher C., Smith-Richardson S., McFarlane S., et al. Phasic insulin dependent diabetes mellitus: manifestations and cellular mechanisms. J Clin Endocrinol Metab 80 70 (1995) 1996-2001
6. Kaneto H., Kajimoto Y., Fujitani Y., et al. Oxidative stress induces 21 expressions in pancreatic Islet cells. Possible implication in beta-cell dysfunction. Diabetology 42 (1999) 1093-1097
7. Sakai K., Matsumoto K., Nishikawa T., et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic B-cells. Biochem Biophys Res Commun 300 (2003) 216-222
8. Robertson R.P., Harmon J., Tran P.O., et al. Glucose toxicity in B-cells. Type 2 diabetes, good radicals gone bad and the glutathione connection. Diabetes 52 (2003) 581-587
9. Haskins K., Kench J., Powers K., et al. Role for oxidative stress in the regeneration of Islet beta cells. J Invest Med 52 (2004) 45-49
10. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
11. Diabetes Prevention Research Group. Reduction in the evidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
12. Chaisson J.L., Josse R.G., Gomis R., et al. Acarbose for prevention of Type 2 diabetes mellitus. The stop - NIDDM randomized trial. Lancet 359 (2002) 2072-2077
13. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting enzyme inhibitor, Ramipril, on cardiovascular events in high risk patients. N Engl J Med 342 (2000) 145-153
14. Hansson L., Lindolm L.H., Niskanen L., et al. Effect of an angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity in hypertension. The Captopril Prevention Project (CAPP) randomized trial. Lancet 353 (1999) 611-616
15. Dahlof B., Devereux R.B., Kjrldsen S., et al. Cardiovascular morbidity and mortality in the Losartan intervention for end-point reduction in hypertension study (LIFE). A randomized trial against atenolol. Lancet 359 (2002) 995-1003
16. Ceriello A., Taboga C., Tonutty L., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short and long term simvastatin treatment. Circulation 106 (2002) 1211-1218
17. Brown M.J., Pacmer C.R., Castaigne A., et al. Morbidity and mortality in patients randomized to double-blind treatment with a long acting calcium channel blocker or diuretic in the International Nifedipine Gits Study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 356 (2000) 366-372
18. Morrison E., Thompson H., Pascoe K., West M., and Fletcher C. Extraction of an hyperglycemic principle from annatto (Bixa ovellano). Trop Geog Med 43 (1991) 184-188
19. Tolan I., Ragoobirsingh D., and Morrison E.Y.St.A. The effect of capsaicin on blood glucose, plasma insulin levels and insulin binding in dog models. Phytother Res 15 (2001) 391-394
20. Lindo RA. Isolation purification and elucidation of the hypoglycemic principles of the cashew bark (Anacardium occidentale). PhD thesis. University of the West Indies; 1999.
21. Morehead C.O., Morehead M., Allen D.M., and Olson R.E. Free radicals in Kwashiorkor. Proc Nutr Soc 46 (1974) 53-68
22. Golden MHN. Personal communication, Department of Basic Medical Sciences, University of the West Indies, Mona Campus, Jamaica; 1989.
23. Morrison E.Y.St.A., Smith-Richardson S., West M., Brooks S., Pascoe K., and Fletcher C. Toxicity of the hyperglycemia-inducing extract of the annatto (Bixa orellano) in the dog. W Indian Med J 36 (1987) 99-103
24. Ragoobirsingh D., Robinson H., and Morrison E.Y.St.A. Effects of cassava cyanoglucoside, linamarin, on blood sugar levels in the dog. J Nutr Biochem 4 (1993) 625-629
25. Paglioso G., D'Amore A., Volpe C., Quatraro A., and Lefebvre P.J. Evidence for a relationship between oxidative stress and insulin action in non-insulin dependent Type 2 diabetic patients. Metabolism 43 (1994) 1426-1429
26. Skrha J., Sindelka G., Haas T., Hilgertova J., and Justora V. Comparison of insulin sensitivity in patients with insulinomas and obese Type 2 diabetes mellitus. Horm Metab Res 28 (1996) 595-598
27. Mullarkey C.J., Edelstein D., and Brownlee M. Free radical generation by early gylcation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173 (1990) 932-939
28. West I.C. Radicals and oxidative stress in diabetes. Diabetes Metab 17 (2000) 171-180
29. Kawamura M., Heinecke J.W., and Chait A. Pathophysiological concentrations of glucose promote oxidative medication of low density lipoprotein by a superoxide dependent pathway. J Clin Invest 94 (1994) 771-778
30. Cerami A., Vlassara H., and Brownlee M. Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11 Suppl. 1 (1988) 73-79
31. Stern M.P. Diabetes and cardiovascular disease. 'The Common Soil' hypothesis. Diabetes 44 4 (1995) 369-374